Why the study?
On the basis of randomized clinical trials and Russian clinical experience, RMSAH experts developed a consensus regarding the use of radiofrequency renal denervation in patients with arterial hypertension.
Does transcatheter radiofrequency denervation of the renal arteries reduce blood pressure in patients with uncontrolled arterial hypertension?
Does transcatheter radiofrequency denervation of the renal arteries reduce blood pressure in patients with uncontrolled arterial hypertension?
The Russian Medical Society for Arterial Hypertension recommends transcatheter renal artery denervation as a possible adjunctive therapy for uncontrolled arterial hypertension in the context of registries and clinical trials.
May support renal denervation for BP reduction in hypertension; leaves open long-term efficacy and optimal patient selection.
Hyperactivity of the sympathetic nervous system is one of the basic mechanisms in the development of arterial hypertension (AH). Transcatheter renal artery denervation is aimed to destroy the renal sympathetic afferent and efferent nerves to achieve a sustained reduction in blood pressure. Since 2017, all II generation studies have demonstrated that sympathetic denervation provides clinically significant BP reduction. Russian Medical Society for Arterial Hypertension (RMSAH) experts consider SD as a possible addition to the antihypertensive strategy in patients with uncontrolled AH and recommend denervation of the renal arteries in registers and clinical trials. On the basis of existing randomized clinical trials, as well as the experience of radiofrequency denervation in Russia, the experts of RMSAH present a consensus and view of the current situation in the field of renal denervation.
No takes yet. Share an insight, caveat, or question.
Danilov et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: